Research in Gastrointestinal Diseases
Basic/translational research
IIS Biodonostia
·San Sebastian ·

The research group co-led by Luis Bujanda and Marta Herreros in pancreatic cancer is part of one of the lines of the Biodonostia Institute and is integrated as a group to the Center for Biomedical Research Network in Liver and Digestive Diseases (CIBEREHD). The group is accredited as one of the research groups of the University of the Basque Country from 2010 to the present. In 2021 they published 49 articles, exceeding 100 impact factor points and with a number of citations in 2022 exceeding 1,500. One of the areas of greatest interest is in the field of digestive oncology and pancreatic cancer. They have led the EPIPANCREAS project and other studies such as the search for diagnostic biomarkers of this disease.

Main publications in pancreatic cancer:

  1. Macias RIR, Muñoz-Bellvís L, Sánchez-Martín A, Arretxe E, Martínez-Arranz I, Lapitz A, Gutiérrez ML, La Casta A, Alonso C, González LM, Avila MA, Martinez- Chantar ML, Castro RE, Bujanda L, Banales JM, Marin JJG. A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma. Cancers (Basel). 2020 May 31;12(6):1433. doi: 10.3390/cancers12061433. PMID: 32486461; PMCID: PMC7352809.
  2. Herreros-Villanueva M, Bujanda L, Ruiz-Rebollo L, Torremocha R, Ramos R, Martín R, Artigas MC. Circulating tumor DNA tracking in patients with pancreatic cancer using next-generation sequencing. Gastroenterol Hepatol. 2022 Oct;45(8):637-644. English, Spanish. doi: 10.1016/j.gastrohep.2021.12.011. Epub 2022 Jan 31. PMID: 35092761.
  3. Carballal S, Balaguer F, Bujanda L, Capellá G, González Santiago S, Jover R, Moreira L, Pineda M, Ruiz Ponte C, Sánchez Heras AB, Serrano Blanch R, Soto JL, Vidal Tocino R, Cubiella J; representing AEG; SEOM; AEGH and IMPaCT-Genomics consortium. Use of multi-gene panels in patients at high risk of hereditary digestive cancer: position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortium. Gastroenterol Hepatol. 2023 Jun 13:S0210-5705(23)00350-3. English, Spanish. doi: 10.1016/j.gastrohep.2023.06.004. Epub ahead of print. PMID: 37315767.
Luis Bujanda Fernandez De Pierola
Marta Herreros Villanueva

Principal Investigator

Group members

  • Luis Bujanda Fernandez De Pierola
  • Marta Herreros-Villanueva
More information

Other groups

Virology and Cellular Immunology Group – Carmen Aguilar

Our group at IrsiCaixa focuses on the development of innovative therapeutic strategies against solid tumors, with a particular emphasis on pancreatic cancer. The group integrates immunological, molecular, and translational approaches to design and evaluate cancer...

Neoantigens and Vaccines Against Cancer – Núria de la Iglesia

The Neoantigens and Cancer Vaccines group (NeoVaCan) is part of the IrsiCaixa Institute for Research on Immunopathologies, a center dedicated to the study of diseasesrelated to the immune system, ranging from viral infections, such as HIV or SARS-CoV-2, to cancer. Our...

Angiogenesis Group – Alfredo Martínez Ramírez

The Angiogenesis Group is part of the Oncology Area of the Biomedical Research Center of La Rioja (CIBIR), located in Logroño, Spain. As the name implies, the Angiogenesis Group focuses on the process of angiogenesis in relation to cancer and other relevant diseases...

See all groups